Frutarom USA has released Benolea (EFLA943), a patented olive leaf extract designed to support cardiovascular health. Benolea’s well-researched blood-pressure-lowering capacity exerts a positive influence on LDL (low density lipoprotein) cholesterol and helps manage blood-sugar levels, according to the company. Benolea also acts as a potent antioxidant and protects blood vessels against cellular damage caused by free radicals. Benolea (EFLA943) is produced through a patented process called EFLAHyperPure. This Swiss technology protects the environment by using vegetable oils and a specialized filtration system instead of toxic solvents to ensure the safe and selective removal of lipophilic and microbial contaminants such as toxins or environmental pollutants. Benolea is stable in film-coated tablets, and is a valuable dosage form for food supplements. It is water-soluble and can be used in still or carbonated beverages at appropriate levels while taking into account national food regulations. For further information: www.frutarom.com
Seong-Jae Yoo, PhD, & Gabriel Giancaspro, PhD, U.S. Pharmacopeial Convention (USP) ||March 1, 2017 USP monographs can serve as useful resources to help dietary supplement manufacturers comply with federal standards.